AWM
TXMD icon

Activest Wealth Management’s TherapeuticsMD TXMD Stock Holding History

Activest Wealth Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88 Hold
40
– – ﹤0.01% 1254
2026
Q1 		$81 Hold
40
– – ﹤0.01% 1165
2025
Q4 		$65 Hold
40
– – ﹤0.01% 1075
2025
Q3 		$43 Hold
40
– – ﹤0.01% 1092
2025
Q2 		$46 Hold
40
– – ﹤0.01% 998
2025
Q1 		$37 Hold
40
– – ﹤0.01% 1000
2024
Q4 		$34 Hold
40
– – ﹤0.01% 800
2024
Q3 		$66 Hold
40
– – ﹤0.01% 532
2024
Q2 		$64 Buy
+40
New +$81 ﹤0.01% 501

Other funds holding TXMD

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FA
Fedenia Advisers Madison, Wisconsin $421M AUM 96.46% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
SWIM
Smallwood Wealth Investment Management Red Bank, New Jersey $229M AUM 23.56% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Activest Wealth Management's TXMD Position: Q2 2026 in Review

Activest Wealth Management held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 40 shares worth $88. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Activest Wealth Management first reported a position in TXMD in Q2 2024 and has held it in 9 quarters since. 9 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

  • Activest Wealth Management held 40 shares of TherapeuticsMD worth $88 as of Q2 2026.
  • Activest Wealth Management left its TherapeuticsMD share count unchanged in Q2 2026.
  • TherapeuticsMD made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1254 holding.
  • Activest Wealth Management first reported a position in TherapeuticsMD in Q2 2024 and has held it in 9 quarters since.
  • 9 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.